Vincentage Pharma Co., Ltd

This early-stage study looked at how two common drugs (rifampin and itraconazole) change the way the body processes a new experimental medicine called VCT220, which is being developed for obesity. A total of 32 healthy adults took part, with each group receiving either VCT220 plu…

This study tested a single dose of VCT220 in 16 people to see how kidney function affects the drug. Half had moderate kidney problems, half had normal kidneys. The goal was to learn how to dose the drug safely for people with kidney issues.

This study looked at how a new drug called VCT220 interacts with three other medicines (repaglinide, rosuvastatin, and digoxin) in 24 healthy overweight adults. Participants took the drugs alone and then with VCT220 to measure changes in drug levels and safety. The goal was to un…